Adipotide 5mg Peptide
Research Use Only
Get Notified When Available
This product is currently out of stock. Enter your email and we'll notify you the moment it's back.
Research Use Only
For in vitro laboratory research by qualified professionals only. Not for human or animal administration. Not intended to treat, prevent, mitigate, or cure any disease. Batch-specific Certificates of Analysis available for all products.
Research Use Only
For in vitro laboratory research by qualified professionals only. Not for human or animal administration. Not intended to treat, prevent, mitigate, or cure any disease. Batch-specific Certificates of Analysis available for all products.
Adipotide works on an unusual premise: rather than acting on adipocytes, it targets the blood vessels that supply them. The homing sequence binds prohibitin on white adipose vasculature endothelium, and the attached KLAKLAK domain then disrupts mitochondrial membranes in those cells, causing vascular regression and secondary adipocyte loss. It is a cytotoxic construct by design, which is the central consideration in handling it, and renal toxicity terminated the primate work that produced its best-known results. Strictly a laboratory research material.
Frequently Bought Together
Adipotide (FTPP) 5mg
5mg
$149 USD
Bundle & Save
$249 USD
Save $14 USD
$314 USD
Save $29 USD
$359 USD
Save $54 USD
$459 USD
Save $94 USD
Click any product above to toggle selection
Related Peptides
Related Research News
Oxytocin's Vital Role in Social and Relationship Bonds
Oxytocin, known as the love hormone, supports social connections through release during touch, trust, and intimacy. Research indicates it aids trust, empathy, and bonding in romantic, parental, and friendly relationships, though effects depend on context and individual factors. This peptide also interacts with stress systems to promote emotional regulation and well-being.
Atosiban Serves as Maintenance Therapy for Preterm Labor
Atosiban, an oxytocin-receptor antagonist marketed in China in 2006, offers maintenance treatment to manage preterm labor risks after initial tocolysis. Clinical trials show it delays delivery better than placebo in some cases and has fewer side effects than beta-2 agonists. Studies highlight its safety and role in reducing recurrent preterm labor episodes.